Aesthetic medicine products. Henkel reports organic sales growth of 3.7 percent; trims full year forecast due to raw material price hike and logistics costs

Derma filler

THE WHAT? Henkel has reported a Q3 organic sales growth of 3.7 percent YOY and 7.5 percent vs 2019, with the rise driven mainly by emerging markets. 

THE DETAILS The company achieved group sales of around 5.1 billion euros, thanks to ‘positive pricing in all business units.’ 

Beauty care sales fell 6.5 percent to 934 million euros, while organic sales were down 3 percent YOY. The consumer business was down due to a significantly lower sales development in body care, said to be due to the ‘continued normalization of demand for soap products’ following the higher demand in 2020 during the pandemic. 

Fat dissolving

The professional beauty business area continued a positive sales performance, with strong growth in North America and a double digit increase in sales in Africa/Middle East and Eastern Europe regions contributing to the growth. 

THE WHY? According to a press release, the stable volume development was ‘characterized by a normalization of demand in consumer businesses and by the ongoing recovery in industrial production.’

However, Henkel has updated and trimmed its full year guidance to 13.5 percent, down from the previously predicted 13.5 – 14.5 percent. 

This was due to the anticipated significant recovery in demand, particularly in the industrial and professional businesses, set to have an impact on its earnings. Likewise the price hike of raw materials as well ‘globally strained supply chains’ are contributing factors.

Aesthetic medicine products are developed and regulated to meet stringent safety and efficacy standards. They are typically administered by trained healthcare professionals such as dermatologists, plastic surgeons, and specialized nurses in clinical settings. These products aim to provide effective solutions for cosmetic enhancement, skin rejuvenation, and overall aesthetic improvement, contributing to both physical appearance and self-confidence.

  Aesthetic medicine products. Edgewell Personal Care acquires feminine and body care brand Billie

Key categories of aesthetic medicine products include:

  • Injectables: This category includes products such as dermal fillers, botulinum toxins (e.g., Botox), and collagen stimulators. These injectables are used to smooth wrinkles, add volume, and improve facial contours.

  • Skin Rejuvenation Treatments: Products like chemical peels, microdermabrasion systems, and laser devices are used to improve skin texture, reduce pigmentation irregularities, and enhance overall skin tone.

  • Skincare Products: These include medical-grade cleansers, moisturizers, serums, and topical treatments containing active ingredients like retinoids, antioxidants, and growth factors. They are formulated to address specific skin concerns such as acne, aging, and hyperpigmentation.

  • Hair Restoration Products: Medical treatments and products designed to promote hair growth and treat conditions such as male and female pattern baldness.

  • Body Contouring and Fat Reduction: Devices and products used for non-surgical body sculpting, such as cryolipolysis (cool sculpting) devices and injectable lipolytics.

  • Cosmeceuticals: High-performance skincare products that bridge the gap between cosmetics and pharmaceuticals, often containing potent ingredients with proven clinical benefits.

  • Wound Care and Scar Management: Products like silicone sheets, gels, and advanced wound dressings used to improve healing and reduce the appearance of scars.